Andrew Feigin - New York Univ Langone Hlth

基本信息

浏览量：34

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 122 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Pepinemab: a SEMA4D Antagonist for Treatment of Huntington's and Other Neurodegenerative Diseases

Andrew Feigin,Elizabeth E Evans,Terrence L Fisher,Maurice Zauderer

Expert opinion on investigational drugsno. 3 (2025): 109-119

引用0浏览0WOS引用

J008 the Phase 3 Proof-Hd Trial Demonstrates Benefits of Pridopidine on Progression in Huntington Disease

Michal Geva,Ralf Reilmann,Andrew Feigin,Anne Rosser,Sandra Kostyk, Kelly Chen,Randal Hand, Diderik Boot,Yael Cohen,Y Paul Goldberg,Michael Hayden

J Clinical therapeutics (2024)

引用0浏览0引用

What Huntington’s Disease Patients Say about Their Illness: an Online Direct-to-Participant Pilot Study

Karen E. Anderson,Lakshmi Arbatti,Abhishek Hosamath,Andrew Feigin,Jody Goldstein,Elise Kayson, Brett L. Kinsler, Lauren Falanga, Lynn Denise,Noelle E. Carlozzi,Samuel Frank, Katie Jackson,Sandra Kostyk,Jennifer L. Purks,Kenneth P. Serbin,Shari Kinel,Christopher A. Beck,Ira Shoulson

JOURNAL OF HUNTINGTONS DISEASEno. 2 (2024): 237-248

引用0浏览0WOS引用

Safety and Efficacy of Laquinimod for Huntington's Disease (LEGATO-HD): a Multicentre, Randomised, Double-Blind, Placebo-Controlled, Phase 2 Study

Ralf Reilmann,Karen E. Anderson,Andrew Feigin,Sarah J. Tabrizi,Blair R. Leavitt,Julie C. Stout,Paola Piccini,Robin Schubert,Pippa Loupe, Anna Wickenberg,Beth Borowsky,Gail Rynkowski,Rita Volkinshtein,Thomas Li,Juha-Matti Savola,Michael Hayden,Mark Forrest Gordon

The Lancet Neurology（2024）

引用5浏览0WOS引用

Analyses of the Phase 3 Trial of Pridopidine’s Outcome on Function in Huntington Disease (PROOF-HD) Demonstrates Efficacy in Participants Without Antidopaminergic Medications (S30.002)

Michal Geva,Ralf Reilmann,Andrew Feigin,Anne Rosser,Sandra Kostyk, Kelly Chen,Munish Mehra,Yael Cohen,Paul Goldberg,Michael Hayden

Neurology（2024）

引用0浏览0引用

Art Therapy As a Comprehensive Complementary Treatment for Parkinson’s Disease

Tom Ettinger,Marygrace Berberian,Ikuko Acosta,Alberto Cucca,Andrew Feigin,Danilo Genovese,Travis Pollen, Julianne Rieders, Rohita Kilachand, Clara Gomez,Girija Kaimal,Milton Biagioni,Alessandro Di Rocco,Felice M. Ghilardi,John-Ross Rizzo

FRONTIERS IN HUMAN NEUROSCIENCE (2023)

引用7浏览0WOS引用

Online Self Report of Problems and Functional Consequences in Huntington Disease: Feasibility and Informativeness

Karen E. Anderson,Lakshmi Arbatti,Abhishek Hosamath,Andrew Feigin,Jody Goldstein,Elise Kayson,Shari Kinel,Christopher Beck,Ira Shoulson

ANNALS OF NEUROLOGY (2023): S179-S179

引用0浏览0引用

Elsevier - Best Research Paper: Topline Results of the PROOF-HD Pivotal Phase 3 Trial: Pridopidine's Outcome on Function in Huntington Disease

Y. Paul Goldberg,Ralf Reilmann,Andrew Feigin,Anne Rosser,Sandra Kostyk,Yael Cohen, Elena Berelovich,Michal Geva,Michael R. Hayden

Journal of the Neurological Sciences (2023): 121063-121063

引用0浏览0引用

SEMA4D Blocking Antibody, Pepinemab, is a Novel Potential Treatment for Neurodegenerative Disease: Clinical Proof of Concept in Phase 2 HD Study Supports Ongoing Clinical Development in Phase 1/2 AD Study

Terrence L Fisher,Elizabeth E Evans,Megan Boise,Amber Foster,Vikas Mishra,Crystal L Mallow,Ernest S Smith,John E Leonard,Andrew Feigin,Eric Siemers,Kimberly Walters, Elizabeth Sheldon, Scott Turner,Martin R. Farlow,Maurice Zauderer

Alzheimer's &amp Dementiano. S7 (2023)

引用1浏览0引用

J09 an Update on the Proof-Hd Phase 3 Trial: Pridopidine’s Outcome on Function in Huntington

Ralf Reilmann,Andrew Feigin,Anne Rosser,Sandra Kostyk,Michal Geva,Noga Gershoni-Emek, Diderik Boot,Yael Cohen,Y. Paul Goldberg,Michael R. Hayden

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2022): A97-A97

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn